FRONT ONCOL 润色咨询

Frontiers in Oncology

出版年份:2011 年文章数:14479 投稿命中率: 开通期刊会员,数据随心看

出版周期:Irregular 自引率:2.1% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2114449, encodeId=65d6211444918, content=收临床case report吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e3a6513284, createdName=ms8000000438373883, createdTime=Mon Feb 13 16:53:23 CST 2023, time=2023-02-13, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2185997, encodeId=c0ab218599e4a, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:十一月中旬投的搞,80多天了,依然还在Independent Review,就回来一个审稿意见,服了,处理速度贼慢,都想撤稿选其他杂志投了,当时投觉得发文量大,所以就投这个,没想到这么坑。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=22ec5549526, createdName=决战, createdTime=Mon Feb 05 13:57:01 CST 2024, time=2024-02-05, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2186002, encodeId=a83d2186002d0, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:投稿快三个月了,还在independent review,才回来一个审稿意见,意见感觉不太行,都想撤稿了,太慢了,非常耽误时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=22ec5549526, createdName=决战, createdTime=Mon Feb 05 14:09:45 CST 2024, time=2024-02-05, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2142329, encodeId=c2152142329ca, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:胃肠肿瘤<br>经验分享:Received date: 14 Mar 2023<br>Editorial assignment start date: 02 Mar 2023<br>Independent review start date: 26 Mar 2023<br>Interactive review activated date: 17 Apr 2023<br>Review finalized date: 05 May 2023<br>Final validation date: 05 May 2023<br><br>到现在停在Final validation已经1个多月了,还是没动静,催了编辑一次,回信说还不确定需要多长时间,会尽快给出FINIAL DECISION。蚌埠住了,F系列现在也那么难投了吗?/哭<br>有没有大神给支个招,这是要拒还是怎么回事呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c18a6547377, createdName=每次投稿都要遇见心软的神, createdTime=Mon Jun 12 09:16:41 CST 2023, time=2023-06-12, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2184228, encodeId=229321842284e, content=偏重的研究方向:肿瘤学<br>经验分享:今年会预警吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05b35438089, createdName=羊0, createdTime=Sat Jan 27 01:28:54 CST 2024, time=2024-01-27, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2173605, encodeId=2ae921e360568, content=从这获得了不少信息,来还愿分享自己的过程<br>7.14 Editorial assignment start <br>7.20 Independent review start <br>7.30 review 1 endorse<br>8.05 review 2 reject <br>8.28 Interactive review activated AE reject<br>8.28 rebuttle submit<br>10.07 更换AE,review 3 审稿<br>10.18 review 3 minor revision<br>10.24 re-submitted manuscript<br>10.26 review 3 endorse<br>10.31 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e4688589769, createdName=ms8000001084196492, createdTime=Thu Dec 07 23:03:38 CST 2023, time=2023-12-07, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2179063, encodeId=e3ea21e906379, content=偏重的研究方向:肿瘤<br>经验分享:这期刊最近submit多久拒稿呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Wed Jan 03 17:03:30 CST 2024, time=2024-01-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2175546, encodeId=1f0021e5546ce, content= 审稿人的回复:I strongly believe if the authors attempt a rewrite sentence by sentence and consider grammar the quality of the work will be improved tremendously and it will be useful article to scientific community everywhere. In its current form, I am not able to recommend this article for publication.这是拒了的意思吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbde5575440, createdName=ms8000000268717089, createdTime=Mon Dec 18 09:37:50 CST 2023, time=2023-12-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2178638, encodeId=c9ba21e86387a, content=偏重的研究方向:肿瘤<br>经验分享:23.12.27 submit 24.1.1 仍然initial validation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Mon Jan 01 18:38:20 CST 2024, time=2024-01-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2160922, encodeId=32312160922ec, content=技术审查一个多月了,催了几次都说会催诚信团队,但至今都卡在技术审查这步,有人遇到过同样情况吗😮‍💨, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=009a8811870, createdName=ms1000000556586108, createdTime=Wed Oct 04 17:16:56 CST 2023, time=2023-10-04, status=1, ipAttribution=湖南省)]
    2023-02-13 ms8000000438373883 来自江西省

    收临床case report吗

    3

    展开3条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2114449, encodeId=65d6211444918, content=收临床case report吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e3a6513284, createdName=ms8000000438373883, createdTime=Mon Feb 13 16:53:23 CST 2023, time=2023-02-13, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2185997, encodeId=c0ab218599e4a, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:十一月中旬投的搞,80多天了,依然还在Independent Review,就回来一个审稿意见,服了,处理速度贼慢,都想撤稿选其他杂志投了,当时投觉得发文量大,所以就投这个,没想到这么坑。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=22ec5549526, createdName=决战, createdTime=Mon Feb 05 13:57:01 CST 2024, time=2024-02-05, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2186002, encodeId=a83d2186002d0, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:投稿快三个月了,还在independent review,才回来一个审稿意见,意见感觉不太行,都想撤稿了,太慢了,非常耽误时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=22ec5549526, createdName=决战, createdTime=Mon Feb 05 14:09:45 CST 2024, time=2024-02-05, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2142329, encodeId=c2152142329ca, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:胃肠肿瘤<br>经验分享:Received date: 14 Mar 2023<br>Editorial assignment start date: 02 Mar 2023<br>Independent review start date: 26 Mar 2023<br>Interactive review activated date: 17 Apr 2023<br>Review finalized date: 05 May 2023<br>Final validation date: 05 May 2023<br><br>到现在停在Final validation已经1个多月了,还是没动静,催了编辑一次,回信说还不确定需要多长时间,会尽快给出FINIAL DECISION。蚌埠住了,F系列现在也那么难投了吗?/哭<br>有没有大神给支个招,这是要拒还是怎么回事呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c18a6547377, createdName=每次投稿都要遇见心软的神, createdTime=Mon Jun 12 09:16:41 CST 2023, time=2023-06-12, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2184228, encodeId=229321842284e, content=偏重的研究方向:肿瘤学<br>经验分享:今年会预警吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05b35438089, createdName=羊0, createdTime=Sat Jan 27 01:28:54 CST 2024, time=2024-01-27, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2173605, encodeId=2ae921e360568, content=从这获得了不少信息,来还愿分享自己的过程<br>7.14 Editorial assignment start <br>7.20 Independent review start <br>7.30 review 1 endorse<br>8.05 review 2 reject <br>8.28 Interactive review activated AE reject<br>8.28 rebuttle submit<br>10.07 更换AE,review 3 审稿<br>10.18 review 3 minor revision<br>10.24 re-submitted manuscript<br>10.26 review 3 endorse<br>10.31 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e4688589769, createdName=ms8000001084196492, createdTime=Thu Dec 07 23:03:38 CST 2023, time=2023-12-07, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2179063, encodeId=e3ea21e906379, content=偏重的研究方向:肿瘤<br>经验分享:这期刊最近submit多久拒稿呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Wed Jan 03 17:03:30 CST 2024, time=2024-01-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2175546, encodeId=1f0021e5546ce, content= 审稿人的回复:I strongly believe if the authors attempt a rewrite sentence by sentence and consider grammar the quality of the work will be improved tremendously and it will be useful article to scientific community everywhere. In its current form, I am not able to recommend this article for publication.这是拒了的意思吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbde5575440, createdName=ms8000000268717089, createdTime=Mon Dec 18 09:37:50 CST 2023, time=2023-12-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2178638, encodeId=c9ba21e86387a, content=偏重的研究方向:肿瘤<br>经验分享:23.12.27 submit 24.1.1 仍然initial validation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Mon Jan 01 18:38:20 CST 2024, time=2024-01-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2160922, encodeId=32312160922ec, content=技术审查一个多月了,催了几次都说会催诚信团队,但至今都卡在技术审查这步,有人遇到过同样情况吗😮‍💨, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=009a8811870, createdName=ms1000000556586108, createdTime=Wed Oct 04 17:16:56 CST 2023, time=2023-10-04, status=1, ipAttribution=湖南省)]
    2024-02-05 决战 来自湖北省

    审稿速度:6.0 | 投稿命中率:25.0
    经验分享:十一月中旬投的搞,80多天了,依然还在Independent Review,就回来一个审稿意见,服了,处理速度贼慢,都想撤稿选其他杂志投了,当时投觉得发文量大,所以就投这个,没想到这么坑。。。

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2114449, encodeId=65d6211444918, content=收临床case report吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e3a6513284, createdName=ms8000000438373883, createdTime=Mon Feb 13 16:53:23 CST 2023, time=2023-02-13, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2185997, encodeId=c0ab218599e4a, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:十一月中旬投的搞,80多天了,依然还在Independent Review,就回来一个审稿意见,服了,处理速度贼慢,都想撤稿选其他杂志投了,当时投觉得发文量大,所以就投这个,没想到这么坑。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=22ec5549526, createdName=决战, createdTime=Mon Feb 05 13:57:01 CST 2024, time=2024-02-05, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2186002, encodeId=a83d2186002d0, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:投稿快三个月了,还在independent review,才回来一个审稿意见,意见感觉不太行,都想撤稿了,太慢了,非常耽误时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=22ec5549526, createdName=决战, createdTime=Mon Feb 05 14:09:45 CST 2024, time=2024-02-05, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2142329, encodeId=c2152142329ca, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:胃肠肿瘤<br>经验分享:Received date: 14 Mar 2023<br>Editorial assignment start date: 02 Mar 2023<br>Independent review start date: 26 Mar 2023<br>Interactive review activated date: 17 Apr 2023<br>Review finalized date: 05 May 2023<br>Final validation date: 05 May 2023<br><br>到现在停在Final validation已经1个多月了,还是没动静,催了编辑一次,回信说还不确定需要多长时间,会尽快给出FINIAL DECISION。蚌埠住了,F系列现在也那么难投了吗?/哭<br>有没有大神给支个招,这是要拒还是怎么回事呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c18a6547377, createdName=每次投稿都要遇见心软的神, createdTime=Mon Jun 12 09:16:41 CST 2023, time=2023-06-12, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2184228, encodeId=229321842284e, content=偏重的研究方向:肿瘤学<br>经验分享:今年会预警吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05b35438089, createdName=羊0, createdTime=Sat Jan 27 01:28:54 CST 2024, time=2024-01-27, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2173605, encodeId=2ae921e360568, content=从这获得了不少信息,来还愿分享自己的过程<br>7.14 Editorial assignment start <br>7.20 Independent review start <br>7.30 review 1 endorse<br>8.05 review 2 reject <br>8.28 Interactive review activated AE reject<br>8.28 rebuttle submit<br>10.07 更换AE,review 3 审稿<br>10.18 review 3 minor revision<br>10.24 re-submitted manuscript<br>10.26 review 3 endorse<br>10.31 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e4688589769, createdName=ms8000001084196492, createdTime=Thu Dec 07 23:03:38 CST 2023, time=2023-12-07, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2179063, encodeId=e3ea21e906379, content=偏重的研究方向:肿瘤<br>经验分享:这期刊最近submit多久拒稿呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Wed Jan 03 17:03:30 CST 2024, time=2024-01-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2175546, encodeId=1f0021e5546ce, content= 审稿人的回复:I strongly believe if the authors attempt a rewrite sentence by sentence and consider grammar the quality of the work will be improved tremendously and it will be useful article to scientific community everywhere. In its current form, I am not able to recommend this article for publication.这是拒了的意思吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbde5575440, createdName=ms8000000268717089, createdTime=Mon Dec 18 09:37:50 CST 2023, time=2023-12-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2178638, encodeId=c9ba21e86387a, content=偏重的研究方向:肿瘤<br>经验分享:23.12.27 submit 24.1.1 仍然initial validation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Mon Jan 01 18:38:20 CST 2024, time=2024-01-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2160922, encodeId=32312160922ec, content=技术审查一个多月了,催了几次都说会催诚信团队,但至今都卡在技术审查这步,有人遇到过同样情况吗😮‍💨, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=009a8811870, createdName=ms1000000556586108, createdTime=Wed Oct 04 17:16:56 CST 2023, time=2023-10-04, status=1, ipAttribution=湖南省)]
    2024-02-05 决战 来自湖北省

    审稿速度:6.0 | 投稿命中率:50.0
    偏重的研究方向:肿瘤
    经验分享:投稿快三个月了,还在independent review,才回来一个审稿意见,意见感觉不太行,都想撤稿了,太慢了,非常耽误时间

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2114449, encodeId=65d6211444918, content=收临床case report吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e3a6513284, createdName=ms8000000438373883, createdTime=Mon Feb 13 16:53:23 CST 2023, time=2023-02-13, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2185997, encodeId=c0ab218599e4a, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:十一月中旬投的搞,80多天了,依然还在Independent Review,就回来一个审稿意见,服了,处理速度贼慢,都想撤稿选其他杂志投了,当时投觉得发文量大,所以就投这个,没想到这么坑。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=22ec5549526, createdName=决战, createdTime=Mon Feb 05 13:57:01 CST 2024, time=2024-02-05, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2186002, encodeId=a83d2186002d0, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:投稿快三个月了,还在independent review,才回来一个审稿意见,意见感觉不太行,都想撤稿了,太慢了,非常耽误时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=22ec5549526, createdName=决战, createdTime=Mon Feb 05 14:09:45 CST 2024, time=2024-02-05, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2142329, encodeId=c2152142329ca, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:胃肠肿瘤<br>经验分享:Received date: 14 Mar 2023<br>Editorial assignment start date: 02 Mar 2023<br>Independent review start date: 26 Mar 2023<br>Interactive review activated date: 17 Apr 2023<br>Review finalized date: 05 May 2023<br>Final validation date: 05 May 2023<br><br>到现在停在Final validation已经1个多月了,还是没动静,催了编辑一次,回信说还不确定需要多长时间,会尽快给出FINIAL DECISION。蚌埠住了,F系列现在也那么难投了吗?/哭<br>有没有大神给支个招,这是要拒还是怎么回事呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c18a6547377, createdName=每次投稿都要遇见心软的神, createdTime=Mon Jun 12 09:16:41 CST 2023, time=2023-06-12, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2184228, encodeId=229321842284e, content=偏重的研究方向:肿瘤学<br>经验分享:今年会预警吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05b35438089, createdName=羊0, createdTime=Sat Jan 27 01:28:54 CST 2024, time=2024-01-27, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2173605, encodeId=2ae921e360568, content=从这获得了不少信息,来还愿分享自己的过程<br>7.14 Editorial assignment start <br>7.20 Independent review start <br>7.30 review 1 endorse<br>8.05 review 2 reject <br>8.28 Interactive review activated AE reject<br>8.28 rebuttle submit<br>10.07 更换AE,review 3 审稿<br>10.18 review 3 minor revision<br>10.24 re-submitted manuscript<br>10.26 review 3 endorse<br>10.31 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e4688589769, createdName=ms8000001084196492, createdTime=Thu Dec 07 23:03:38 CST 2023, time=2023-12-07, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2179063, encodeId=e3ea21e906379, content=偏重的研究方向:肿瘤<br>经验分享:这期刊最近submit多久拒稿呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Wed Jan 03 17:03:30 CST 2024, time=2024-01-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2175546, encodeId=1f0021e5546ce, content= 审稿人的回复:I strongly believe if the authors attempt a rewrite sentence by sentence and consider grammar the quality of the work will be improved tremendously and it will be useful article to scientific community everywhere. In its current form, I am not able to recommend this article for publication.这是拒了的意思吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbde5575440, createdName=ms8000000268717089, createdTime=Mon Dec 18 09:37:50 CST 2023, time=2023-12-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2178638, encodeId=c9ba21e86387a, content=偏重的研究方向:肿瘤<br>经验分享:23.12.27 submit 24.1.1 仍然initial validation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Mon Jan 01 18:38:20 CST 2024, time=2024-01-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2160922, encodeId=32312160922ec, content=技术审查一个多月了,催了几次都说会催诚信团队,但至今都卡在技术审查这步,有人遇到过同样情况吗😮‍💨, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=009a8811870, createdName=ms1000000556586108, createdTime=Wed Oct 04 17:16:56 CST 2023, time=2023-10-04, status=1, ipAttribution=湖南省)]
    2023-06-12 每次投稿都要遇见心软的神 来自河南省

    审稿速度:3.0 | 投稿命中率:50.0
    偏重的研究方向:胃肠肿瘤
    经验分享:Received date: 14 Mar 2023
    Editorial assignment start date: 02 Mar 2023
    Independent review start date: 26 Mar 2023
    Interactive review activated date: 17 Apr 2023
    Review finalized date: 05 May 2023
    Final validation date: 05 May 2023

    到现在停在Final validation已经1个多月了,还是没动静,催了编辑一次,回信说还不确定需要多长时间,会尽快给出FINIAL DECISION。蚌埠住了,F系列现在也那么难投了吗?/哭
    有没有大神给支个招,这是要拒还是怎么回事呀?

    1

    展开1条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2114449, encodeId=65d6211444918, content=收临床case report吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e3a6513284, createdName=ms8000000438373883, createdTime=Mon Feb 13 16:53:23 CST 2023, time=2023-02-13, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2185997, encodeId=c0ab218599e4a, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:十一月中旬投的搞,80多天了,依然还在Independent Review,就回来一个审稿意见,服了,处理速度贼慢,都想撤稿选其他杂志投了,当时投觉得发文量大,所以就投这个,没想到这么坑。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=22ec5549526, createdName=决战, createdTime=Mon Feb 05 13:57:01 CST 2024, time=2024-02-05, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2186002, encodeId=a83d2186002d0, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:投稿快三个月了,还在independent review,才回来一个审稿意见,意见感觉不太行,都想撤稿了,太慢了,非常耽误时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=22ec5549526, createdName=决战, createdTime=Mon Feb 05 14:09:45 CST 2024, time=2024-02-05, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2142329, encodeId=c2152142329ca, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:胃肠肿瘤<br>经验分享:Received date: 14 Mar 2023<br>Editorial assignment start date: 02 Mar 2023<br>Independent review start date: 26 Mar 2023<br>Interactive review activated date: 17 Apr 2023<br>Review finalized date: 05 May 2023<br>Final validation date: 05 May 2023<br><br>到现在停在Final validation已经1个多月了,还是没动静,催了编辑一次,回信说还不确定需要多长时间,会尽快给出FINIAL DECISION。蚌埠住了,F系列现在也那么难投了吗?/哭<br>有没有大神给支个招,这是要拒还是怎么回事呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c18a6547377, createdName=每次投稿都要遇见心软的神, createdTime=Mon Jun 12 09:16:41 CST 2023, time=2023-06-12, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2184228, encodeId=229321842284e, content=偏重的研究方向:肿瘤学<br>经验分享:今年会预警吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05b35438089, createdName=羊0, createdTime=Sat Jan 27 01:28:54 CST 2024, time=2024-01-27, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2173605, encodeId=2ae921e360568, content=从这获得了不少信息,来还愿分享自己的过程<br>7.14 Editorial assignment start <br>7.20 Independent review start <br>7.30 review 1 endorse<br>8.05 review 2 reject <br>8.28 Interactive review activated AE reject<br>8.28 rebuttle submit<br>10.07 更换AE,review 3 审稿<br>10.18 review 3 minor revision<br>10.24 re-submitted manuscript<br>10.26 review 3 endorse<br>10.31 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e4688589769, createdName=ms8000001084196492, createdTime=Thu Dec 07 23:03:38 CST 2023, time=2023-12-07, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2179063, encodeId=e3ea21e906379, content=偏重的研究方向:肿瘤<br>经验分享:这期刊最近submit多久拒稿呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Wed Jan 03 17:03:30 CST 2024, time=2024-01-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2175546, encodeId=1f0021e5546ce, content= 审稿人的回复:I strongly believe if the authors attempt a rewrite sentence by sentence and consider grammar the quality of the work will be improved tremendously and it will be useful article to scientific community everywhere. In its current form, I am not able to recommend this article for publication.这是拒了的意思吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbde5575440, createdName=ms8000000268717089, createdTime=Mon Dec 18 09:37:50 CST 2023, time=2023-12-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2178638, encodeId=c9ba21e86387a, content=偏重的研究方向:肿瘤<br>经验分享:23.12.27 submit 24.1.1 仍然initial validation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Mon Jan 01 18:38:20 CST 2024, time=2024-01-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2160922, encodeId=32312160922ec, content=技术审查一个多月了,催了几次都说会催诚信团队,但至今都卡在技术审查这步,有人遇到过同样情况吗😮‍💨, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=009a8811870, createdName=ms1000000556586108, createdTime=Wed Oct 04 17:16:56 CST 2023, time=2023-10-04, status=1, ipAttribution=湖南省)]
    2024-01-27 羊0 来自福建省

    偏重的研究方向:肿瘤学
    经验分享:今年会预警吧

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2114449, encodeId=65d6211444918, content=收临床case report吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e3a6513284, createdName=ms8000000438373883, createdTime=Mon Feb 13 16:53:23 CST 2023, time=2023-02-13, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2185997, encodeId=c0ab218599e4a, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:十一月中旬投的搞,80多天了,依然还在Independent Review,就回来一个审稿意见,服了,处理速度贼慢,都想撤稿选其他杂志投了,当时投觉得发文量大,所以就投这个,没想到这么坑。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=22ec5549526, createdName=决战, createdTime=Mon Feb 05 13:57:01 CST 2024, time=2024-02-05, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2186002, encodeId=a83d2186002d0, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:投稿快三个月了,还在independent review,才回来一个审稿意见,意见感觉不太行,都想撤稿了,太慢了,非常耽误时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=22ec5549526, createdName=决战, createdTime=Mon Feb 05 14:09:45 CST 2024, time=2024-02-05, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2142329, encodeId=c2152142329ca, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:胃肠肿瘤<br>经验分享:Received date: 14 Mar 2023<br>Editorial assignment start date: 02 Mar 2023<br>Independent review start date: 26 Mar 2023<br>Interactive review activated date: 17 Apr 2023<br>Review finalized date: 05 May 2023<br>Final validation date: 05 May 2023<br><br>到现在停在Final validation已经1个多月了,还是没动静,催了编辑一次,回信说还不确定需要多长时间,会尽快给出FINIAL DECISION。蚌埠住了,F系列现在也那么难投了吗?/哭<br>有没有大神给支个招,这是要拒还是怎么回事呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c18a6547377, createdName=每次投稿都要遇见心软的神, createdTime=Mon Jun 12 09:16:41 CST 2023, time=2023-06-12, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2184228, encodeId=229321842284e, content=偏重的研究方向:肿瘤学<br>经验分享:今年会预警吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05b35438089, createdName=羊0, createdTime=Sat Jan 27 01:28:54 CST 2024, time=2024-01-27, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2173605, encodeId=2ae921e360568, content=从这获得了不少信息,来还愿分享自己的过程<br>7.14 Editorial assignment start <br>7.20 Independent review start <br>7.30 review 1 endorse<br>8.05 review 2 reject <br>8.28 Interactive review activated AE reject<br>8.28 rebuttle submit<br>10.07 更换AE,review 3 审稿<br>10.18 review 3 minor revision<br>10.24 re-submitted manuscript<br>10.26 review 3 endorse<br>10.31 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e4688589769, createdName=ms8000001084196492, createdTime=Thu Dec 07 23:03:38 CST 2023, time=2023-12-07, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2179063, encodeId=e3ea21e906379, content=偏重的研究方向:肿瘤<br>经验分享:这期刊最近submit多久拒稿呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Wed Jan 03 17:03:30 CST 2024, time=2024-01-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2175546, encodeId=1f0021e5546ce, content= 审稿人的回复:I strongly believe if the authors attempt a rewrite sentence by sentence and consider grammar the quality of the work will be improved tremendously and it will be useful article to scientific community everywhere. In its current form, I am not able to recommend this article for publication.这是拒了的意思吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbde5575440, createdName=ms8000000268717089, createdTime=Mon Dec 18 09:37:50 CST 2023, time=2023-12-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2178638, encodeId=c9ba21e86387a, content=偏重的研究方向:肿瘤<br>经验分享:23.12.27 submit 24.1.1 仍然initial validation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Mon Jan 01 18:38:20 CST 2024, time=2024-01-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2160922, encodeId=32312160922ec, content=技术审查一个多月了,催了几次都说会催诚信团队,但至今都卡在技术审查这步,有人遇到过同样情况吗😮‍💨, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=009a8811870, createdName=ms1000000556586108, createdTime=Wed Oct 04 17:16:56 CST 2023, time=2023-10-04, status=1, ipAttribution=湖南省)]
    2023-12-07 ms8000001084196492 来自河北省

    从这获得了不少信息,来还愿分享自己的过程
    7.14 Editorial assignment start
    7.20 Independent review start
    7.30 review 1 endorse
    8.05 review 2 reject
    8.28 Interactive review activated AE reject
    8.28 rebuttle submit
    10.07 更换AE,review 3 审稿
    10.18 review 3 minor revision
    10.24 re-submitted manuscript
    10.26 review 3 endorse
    10.31 accept

    1

    展开1条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2114449, encodeId=65d6211444918, content=收临床case report吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e3a6513284, createdName=ms8000000438373883, createdTime=Mon Feb 13 16:53:23 CST 2023, time=2023-02-13, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2185997, encodeId=c0ab218599e4a, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:十一月中旬投的搞,80多天了,依然还在Independent Review,就回来一个审稿意见,服了,处理速度贼慢,都想撤稿选其他杂志投了,当时投觉得发文量大,所以就投这个,没想到这么坑。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=22ec5549526, createdName=决战, createdTime=Mon Feb 05 13:57:01 CST 2024, time=2024-02-05, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2186002, encodeId=a83d2186002d0, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:投稿快三个月了,还在independent review,才回来一个审稿意见,意见感觉不太行,都想撤稿了,太慢了,非常耽误时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=22ec5549526, createdName=决战, createdTime=Mon Feb 05 14:09:45 CST 2024, time=2024-02-05, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2142329, encodeId=c2152142329ca, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:胃肠肿瘤<br>经验分享:Received date: 14 Mar 2023<br>Editorial assignment start date: 02 Mar 2023<br>Independent review start date: 26 Mar 2023<br>Interactive review activated date: 17 Apr 2023<br>Review finalized date: 05 May 2023<br>Final validation date: 05 May 2023<br><br>到现在停在Final validation已经1个多月了,还是没动静,催了编辑一次,回信说还不确定需要多长时间,会尽快给出FINIAL DECISION。蚌埠住了,F系列现在也那么难投了吗?/哭<br>有没有大神给支个招,这是要拒还是怎么回事呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c18a6547377, createdName=每次投稿都要遇见心软的神, createdTime=Mon Jun 12 09:16:41 CST 2023, time=2023-06-12, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2184228, encodeId=229321842284e, content=偏重的研究方向:肿瘤学<br>经验分享:今年会预警吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05b35438089, createdName=羊0, createdTime=Sat Jan 27 01:28:54 CST 2024, time=2024-01-27, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2173605, encodeId=2ae921e360568, content=从这获得了不少信息,来还愿分享自己的过程<br>7.14 Editorial assignment start <br>7.20 Independent review start <br>7.30 review 1 endorse<br>8.05 review 2 reject <br>8.28 Interactive review activated AE reject<br>8.28 rebuttle submit<br>10.07 更换AE,review 3 审稿<br>10.18 review 3 minor revision<br>10.24 re-submitted manuscript<br>10.26 review 3 endorse<br>10.31 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e4688589769, createdName=ms8000001084196492, createdTime=Thu Dec 07 23:03:38 CST 2023, time=2023-12-07, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2179063, encodeId=e3ea21e906379, content=偏重的研究方向:肿瘤<br>经验分享:这期刊最近submit多久拒稿呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Wed Jan 03 17:03:30 CST 2024, time=2024-01-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2175546, encodeId=1f0021e5546ce, content= 审稿人的回复:I strongly believe if the authors attempt a rewrite sentence by sentence and consider grammar the quality of the work will be improved tremendously and it will be useful article to scientific community everywhere. In its current form, I am not able to recommend this article for publication.这是拒了的意思吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbde5575440, createdName=ms8000000268717089, createdTime=Mon Dec 18 09:37:50 CST 2023, time=2023-12-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2178638, encodeId=c9ba21e86387a, content=偏重的研究方向:肿瘤<br>经验分享:23.12.27 submit 24.1.1 仍然initial validation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Mon Jan 01 18:38:20 CST 2024, time=2024-01-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2160922, encodeId=32312160922ec, content=技术审查一个多月了,催了几次都说会催诚信团队,但至今都卡在技术审查这步,有人遇到过同样情况吗😮‍💨, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=009a8811870, createdName=ms1000000556586108, createdTime=Wed Oct 04 17:16:56 CST 2023, time=2023-10-04, status=1, ipAttribution=湖南省)]
    2024-01-03 ms4000001668897773 来自北京

    偏重的研究方向:肿瘤
    经验分享:这期刊最近submit多久拒稿呢?

    1

    展开1条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2114449, encodeId=65d6211444918, content=收临床case report吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e3a6513284, createdName=ms8000000438373883, createdTime=Mon Feb 13 16:53:23 CST 2023, time=2023-02-13, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2185997, encodeId=c0ab218599e4a, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:十一月中旬投的搞,80多天了,依然还在Independent Review,就回来一个审稿意见,服了,处理速度贼慢,都想撤稿选其他杂志投了,当时投觉得发文量大,所以就投这个,没想到这么坑。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=22ec5549526, createdName=决战, createdTime=Mon Feb 05 13:57:01 CST 2024, time=2024-02-05, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2186002, encodeId=a83d2186002d0, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:投稿快三个月了,还在independent review,才回来一个审稿意见,意见感觉不太行,都想撤稿了,太慢了,非常耽误时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=22ec5549526, createdName=决战, createdTime=Mon Feb 05 14:09:45 CST 2024, time=2024-02-05, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2142329, encodeId=c2152142329ca, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:胃肠肿瘤<br>经验分享:Received date: 14 Mar 2023<br>Editorial assignment start date: 02 Mar 2023<br>Independent review start date: 26 Mar 2023<br>Interactive review activated date: 17 Apr 2023<br>Review finalized date: 05 May 2023<br>Final validation date: 05 May 2023<br><br>到现在停在Final validation已经1个多月了,还是没动静,催了编辑一次,回信说还不确定需要多长时间,会尽快给出FINIAL DECISION。蚌埠住了,F系列现在也那么难投了吗?/哭<br>有没有大神给支个招,这是要拒还是怎么回事呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c18a6547377, createdName=每次投稿都要遇见心软的神, createdTime=Mon Jun 12 09:16:41 CST 2023, time=2023-06-12, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2184228, encodeId=229321842284e, content=偏重的研究方向:肿瘤学<br>经验分享:今年会预警吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05b35438089, createdName=羊0, createdTime=Sat Jan 27 01:28:54 CST 2024, time=2024-01-27, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2173605, encodeId=2ae921e360568, content=从这获得了不少信息,来还愿分享自己的过程<br>7.14 Editorial assignment start <br>7.20 Independent review start <br>7.30 review 1 endorse<br>8.05 review 2 reject <br>8.28 Interactive review activated AE reject<br>8.28 rebuttle submit<br>10.07 更换AE,review 3 审稿<br>10.18 review 3 minor revision<br>10.24 re-submitted manuscript<br>10.26 review 3 endorse<br>10.31 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e4688589769, createdName=ms8000001084196492, createdTime=Thu Dec 07 23:03:38 CST 2023, time=2023-12-07, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2179063, encodeId=e3ea21e906379, content=偏重的研究方向:肿瘤<br>经验分享:这期刊最近submit多久拒稿呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Wed Jan 03 17:03:30 CST 2024, time=2024-01-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2175546, encodeId=1f0021e5546ce, content= 审稿人的回复:I strongly believe if the authors attempt a rewrite sentence by sentence and consider grammar the quality of the work will be improved tremendously and it will be useful article to scientific community everywhere. In its current form, I am not able to recommend this article for publication.这是拒了的意思吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbde5575440, createdName=ms8000000268717089, createdTime=Mon Dec 18 09:37:50 CST 2023, time=2023-12-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2178638, encodeId=c9ba21e86387a, content=偏重的研究方向:肿瘤<br>经验分享:23.12.27 submit 24.1.1 仍然initial validation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Mon Jan 01 18:38:20 CST 2024, time=2024-01-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2160922, encodeId=32312160922ec, content=技术审查一个多月了,催了几次都说会催诚信团队,但至今都卡在技术审查这步,有人遇到过同样情况吗😮‍💨, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=009a8811870, createdName=ms1000000556586108, createdTime=Wed Oct 04 17:16:56 CST 2023, time=2023-10-04, status=1, ipAttribution=湖南省)]
    2023-12-18 ms8000000268717089 来自广东省

    审稿人的回复:I strongly believe if the authors attempt a rewrite sentence by sentence and consider grammar the quality of the work will be improved tremendously and it will be useful article to scientific community everywhere. In its current form, I am not able to recommend this article for publication.这是拒了的意思吗?

    1

    展开1条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2114449, encodeId=65d6211444918, content=收临床case report吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e3a6513284, createdName=ms8000000438373883, createdTime=Mon Feb 13 16:53:23 CST 2023, time=2023-02-13, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2185997, encodeId=c0ab218599e4a, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:十一月中旬投的搞,80多天了,依然还在Independent Review,就回来一个审稿意见,服了,处理速度贼慢,都想撤稿选其他杂志投了,当时投觉得发文量大,所以就投这个,没想到这么坑。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=22ec5549526, createdName=决战, createdTime=Mon Feb 05 13:57:01 CST 2024, time=2024-02-05, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2186002, encodeId=a83d2186002d0, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:投稿快三个月了,还在independent review,才回来一个审稿意见,意见感觉不太行,都想撤稿了,太慢了,非常耽误时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=22ec5549526, createdName=决战, createdTime=Mon Feb 05 14:09:45 CST 2024, time=2024-02-05, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2142329, encodeId=c2152142329ca, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:胃肠肿瘤<br>经验分享:Received date: 14 Mar 2023<br>Editorial assignment start date: 02 Mar 2023<br>Independent review start date: 26 Mar 2023<br>Interactive review activated date: 17 Apr 2023<br>Review finalized date: 05 May 2023<br>Final validation date: 05 May 2023<br><br>到现在停在Final validation已经1个多月了,还是没动静,催了编辑一次,回信说还不确定需要多长时间,会尽快给出FINIAL DECISION。蚌埠住了,F系列现在也那么难投了吗?/哭<br>有没有大神给支个招,这是要拒还是怎么回事呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c18a6547377, createdName=每次投稿都要遇见心软的神, createdTime=Mon Jun 12 09:16:41 CST 2023, time=2023-06-12, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2184228, encodeId=229321842284e, content=偏重的研究方向:肿瘤学<br>经验分享:今年会预警吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05b35438089, createdName=羊0, createdTime=Sat Jan 27 01:28:54 CST 2024, time=2024-01-27, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2173605, encodeId=2ae921e360568, content=从这获得了不少信息,来还愿分享自己的过程<br>7.14 Editorial assignment start <br>7.20 Independent review start <br>7.30 review 1 endorse<br>8.05 review 2 reject <br>8.28 Interactive review activated AE reject<br>8.28 rebuttle submit<br>10.07 更换AE,review 3 审稿<br>10.18 review 3 minor revision<br>10.24 re-submitted manuscript<br>10.26 review 3 endorse<br>10.31 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e4688589769, createdName=ms8000001084196492, createdTime=Thu Dec 07 23:03:38 CST 2023, time=2023-12-07, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2179063, encodeId=e3ea21e906379, content=偏重的研究方向:肿瘤<br>经验分享:这期刊最近submit多久拒稿呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Wed Jan 03 17:03:30 CST 2024, time=2024-01-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2175546, encodeId=1f0021e5546ce, content= 审稿人的回复:I strongly believe if the authors attempt a rewrite sentence by sentence and consider grammar the quality of the work will be improved tremendously and it will be useful article to scientific community everywhere. In its current form, I am not able to recommend this article for publication.这是拒了的意思吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbde5575440, createdName=ms8000000268717089, createdTime=Mon Dec 18 09:37:50 CST 2023, time=2023-12-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2178638, encodeId=c9ba21e86387a, content=偏重的研究方向:肿瘤<br>经验分享:23.12.27 submit 24.1.1 仍然initial validation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Mon Jan 01 18:38:20 CST 2024, time=2024-01-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2160922, encodeId=32312160922ec, content=技术审查一个多月了,催了几次都说会催诚信团队,但至今都卡在技术审查这步,有人遇到过同样情况吗😮‍💨, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=009a8811870, createdName=ms1000000556586108, createdTime=Wed Oct 04 17:16:56 CST 2023, time=2023-10-04, status=1, ipAttribution=湖南省)]
    2024-01-01 ms4000001668897773 来自北京

    偏重的研究方向:肿瘤
    经验分享:23.12.27 submit 24.1.1 仍然initial validation

    2

    展开2条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2114449, encodeId=65d6211444918, content=收临床case report吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e3a6513284, createdName=ms8000000438373883, createdTime=Mon Feb 13 16:53:23 CST 2023, time=2023-02-13, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2185997, encodeId=c0ab218599e4a, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:十一月中旬投的搞,80多天了,依然还在Independent Review,就回来一个审稿意见,服了,处理速度贼慢,都想撤稿选其他杂志投了,当时投觉得发文量大,所以就投这个,没想到这么坑。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=22ec5549526, createdName=决战, createdTime=Mon Feb 05 13:57:01 CST 2024, time=2024-02-05, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2186002, encodeId=a83d2186002d0, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:投稿快三个月了,还在independent review,才回来一个审稿意见,意见感觉不太行,都想撤稿了,太慢了,非常耽误时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=22ec5549526, createdName=决战, createdTime=Mon Feb 05 14:09:45 CST 2024, time=2024-02-05, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2142329, encodeId=c2152142329ca, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:胃肠肿瘤<br>经验分享:Received date: 14 Mar 2023<br>Editorial assignment start date: 02 Mar 2023<br>Independent review start date: 26 Mar 2023<br>Interactive review activated date: 17 Apr 2023<br>Review finalized date: 05 May 2023<br>Final validation date: 05 May 2023<br><br>到现在停在Final validation已经1个多月了,还是没动静,催了编辑一次,回信说还不确定需要多长时间,会尽快给出FINIAL DECISION。蚌埠住了,F系列现在也那么难投了吗?/哭<br>有没有大神给支个招,这是要拒还是怎么回事呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c18a6547377, createdName=每次投稿都要遇见心软的神, createdTime=Mon Jun 12 09:16:41 CST 2023, time=2023-06-12, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2184228, encodeId=229321842284e, content=偏重的研究方向:肿瘤学<br>经验分享:今年会预警吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05b35438089, createdName=羊0, createdTime=Sat Jan 27 01:28:54 CST 2024, time=2024-01-27, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2173605, encodeId=2ae921e360568, content=从这获得了不少信息,来还愿分享自己的过程<br>7.14 Editorial assignment start <br>7.20 Independent review start <br>7.30 review 1 endorse<br>8.05 review 2 reject <br>8.28 Interactive review activated AE reject<br>8.28 rebuttle submit<br>10.07 更换AE,review 3 审稿<br>10.18 review 3 minor revision<br>10.24 re-submitted manuscript<br>10.26 review 3 endorse<br>10.31 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e4688589769, createdName=ms8000001084196492, createdTime=Thu Dec 07 23:03:38 CST 2023, time=2023-12-07, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2179063, encodeId=e3ea21e906379, content=偏重的研究方向:肿瘤<br>经验分享:这期刊最近submit多久拒稿呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Wed Jan 03 17:03:30 CST 2024, time=2024-01-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2175546, encodeId=1f0021e5546ce, content= 审稿人的回复:I strongly believe if the authors attempt a rewrite sentence by sentence and consider grammar the quality of the work will be improved tremendously and it will be useful article to scientific community everywhere. In its current form, I am not able to recommend this article for publication.这是拒了的意思吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbde5575440, createdName=ms8000000268717089, createdTime=Mon Dec 18 09:37:50 CST 2023, time=2023-12-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2178638, encodeId=c9ba21e86387a, content=偏重的研究方向:肿瘤<br>经验分享:23.12.27 submit 24.1.1 仍然initial validation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Mon Jan 01 18:38:20 CST 2024, time=2024-01-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2160922, encodeId=32312160922ec, content=技术审查一个多月了,催了几次都说会催诚信团队,但至今都卡在技术审查这步,有人遇到过同样情况吗😮‍💨, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=009a8811870, createdName=ms1000000556586108, createdTime=Wed Oct 04 17:16:56 CST 2023, time=2023-10-04, status=1, ipAttribution=湖南省)]
    2023-10-04 ms1000000556586108 来自湖南省

    技术审查一个多月了,催了几次都说会催诚信团队,但至今都卡在技术审查这步,有人遇到过同样情况吗😮‍💨

    3

    展开3条回复
共500条页码: 2/50页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分